NCT05415904View on ClinicalTrials.gov

Hantavirus Nephropathy in North-Eastern France : Severity Risk Factors and Prognostic Tools

CompletedOBSERVATIONAL

Enrollment

101

Participants

Timeline

Start Date

May 20, 2022

Primary Completion Date

October 30, 2023

Study Completion Date

July 31, 2024

Conditions

Hantavirus NephropathyHantavirus Infection

Interventions

OTHER

HANTA-NE

Observational cohort study

Trial Locations (1)

54000

Central Hospital, Nancy

All Listed Sponsors

lead

Central Hospital, Nancy, France

OTHER